The analysis of the GBM sub group with no copy number alterations revealed that the upregulation of ANRIL is largely restricted to GBMs with no copy number alterations in INK4b/ARF/INK4a locus (Supplementary Figure 7A). Here, CDKN2A is linked to glioblastoma.